[Trending] Global Tumor Ablation Market Size & Share to Hit $ 4.69 Billion by 2030 at a 13.59% CAGR: Growing cases of lung cancer to propel market demand- Facts & Factors

The key market players listed in the tumor ablation report with their sales, revenues and strategies are Boston Scientific Corporation, SonaCare Medical, Ethicon Inc, Chongqing Haifu Medical Technology Co, Medtronic Plc, Neuwave Medical Inc, and others.


SAN FRANCISCO, U.S., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Tumor Ablation Market Size, Share, Growth Analysis Report By Application (Liver Cancer, Kidney Cancer, Lung Cancer, Breast Cancer, and Prostate Cancer), By Technology (Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation Ablation, Cryoablation, and Others), By Treatment (Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030” in its research database.

“According to Facts and Factors, the global tumor ablation market size was worth around USD 1.35 billion in 2021 and is predicted to grow around USD 4.69 billion by 2030 with a compound annual growth rate (CAGR) of roughly 13.59% between 2022 and 2030.”

Tumor Ablation Market Overview:

Tumor ablation is a medical technique used to treat cancer. It is minimally invasive and is a common treatment methodology used for the treatment of various types of cancer including liver, kidney, renal, or lung cancer. It is an important and recommended option for cancer patients who do not show any positive effect of radiotherapy or chemotherapy. Tumor ablation is being considered by many institutes as the first line of treatment in case of benign tumors in the liver or small hepatocellular carcinomas.

Most of the ablation systems consist of a needlelike device and a generator that is used to transport energy directed to the targeted site resulting in acute cellular necrosis. The systems include the use of high-intensity focused ultrasound (HIFU), microwave (MW) laser, or radio-frequency to supply enough energy for heating the targeted tissue up to at least 60 degrees Celsius with maximum efficiency. Burning is the process of increasing cancer cell temperature so that the cancer cells die whereas freezing refers to cryoablation which requires decreasing the temperature to below -40 degrees Celsius.

Get a Free Sample PDF of this Research Report for more Insights - https://www.fnfresearch.com/sample/tumor-ablation-market

Report Scope:

Report AttributeDetails
Market Size in 2021USD 1.35 Billion
Projected Market Size in 2030USD 4.69 Billion
CAGR Growth Rate13.59% CAGR
Base Year2021
Forecast Years2022-2030
Key Market PlayersBoston Scientific Corporation, SonaCare Medical, Ethicon Inc, Chongqing Haifu Medical Technology Co, Medtronic Plc, Neuwave Medical Inc, and others.
Key SegmentBy Application, Technology, Treatment, and Region
Major Regions CoveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Purchase OptionsRequest customized purchase options to meet your research needs.

Key Insights from Primary Research

  • As per the analysis, the tumor ablation market share is likely to grow above a CAGR of around 13.59% between 2022 and 2030.
  • The Tumor Ablation market size was worth around US$ 1.35 billion in 2021 and is estimated to hit approximately US$ 4.69 billion by 2030. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
  • The global tumor ablation market is projected to grow at a significant rate due to the growing number of patients with lung cancer
  • Based on treatment segmentation, surgical ablation was predicted to show maximum market share in the year 2021
  • Based on application segmentation, liver cancer was the leading application in 2021
  • On the basis of region, North America was the leading revenue generator in 2021

Directly Purchase a Copy of the Report | Quick Delivery Available - https://www.fnfresearch.com/buynow/su/tumor-ablation-market

Market Dynamics:

Industry Growth Drivers

  • Growing R&D in the field of tumor ablation

The global tumor ablation market is projected to grow due to the increasing research and development in the field of tumor ablation which is further propelled by the growing number of product innovations, launches, and approvals. Tumor ablation is an effective treatment plan for various cancers, and even though they sometimes are less effective than surgery, the technique has been known to be extremely beneficial for some patients. In many cases, people who are awaiting liver transplants are also treated using tumor ablation.

The rising number of new ablation devices to remove small tumors is a leading factor for global market growth. Microwave ablation (MWA) is gaining popularity for the treatment of localized tumors in different types of organ systems. This is because microwave ablation has shown a higher performance yield as compared to other ablation techniques. In MWA, liver tumors are destroyed by the use of microwave energy since they offer a better speed of tumor destruction. With MWA, medical professionals can target numerous liver tumors simultaneously and they can also target large-sized tumors.

Restraints

  • Increasing research in complementary cancer therapies

One of the key factors that could act as a restraining factor is the growing advancement in alternative methods of cancer treatment. Ablation therapy may not be beneficial for all cancer patients and has limited applications. Other methods like chemotherapy have wide uses in terms of types of cancer that can be treated. As research in other segments grows in the coming years, tumor ablation techniques may lose the momentum they have gained in recent times.

Opportunities & Challenges

The growing demand for minimally invasive techniques may provide growth opportunities while the lack of infrastructure could act as a major challenge.

Tumor Ablation Market: Segmentation Analysis

The global tumor ablation market is segmented based on application, technology, treatment, and others.

Based on application, the global market segments are liver cancer, kidney cancer, lung cancer, breast cancer, and prostate cancer. The global market was dominated by the liver cancer segment in 2021 due to the growing prevalence of the condition as well as the high output efficiency obtained by using tumor ablation techniques in treating cancer cells. The most widely prevalent type of liver cancer is hepatocellular carcinoma which has origins in the main liver cells called hepatocytes. Other types of liver cancer which are less common include hepatoblastoma and intrahepatic cholangiocarcinoma. In almost 43% of the early diagnosed cases of liver cancer, the 5-year survival rate is around 35% as per Cancer.Net

Based on technology, the global market is segmented into microwave ablation, radiofrequency ablation, irreversible electroporation ablation, cryoablation, and others. The global market registered the highest growth in the radiofrequency ablation segment in 2021 since it is one of the most common tumor ablation techniques used in the treatment of small tumors. It makes use of high-energy radio waves where the doctor inserts the probe, through the skin, of the tumor. The radiofrequency range in this method lies between 450 to 500 kHz.

Browse the full “Tumor Ablation Market Size, Share, Growth Analysis Report - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030” Report at https://www.fnfresearch.com/tumor-ablation-market

Regional Analysis:

  • North America to grow with the highest CAGR

North America is projected to register the highest CAGR in the global tumor ablation market with the US leading with surging revenue during the forecast period. The regional growth is attributed to the highly advanced cancer treatment facilities present in the USA which is home to some of the best cancer treatment centers including Johns Hopkins Hospital and Abramson Cancer Center attracting more patients to the region for treatment.

Studies have proven that the cancer survival rate due to treatment in the US is better than in any other advanced country in the world and as of 2022, the University of Texas MD Anderson Cancer Center has managed to hold its title as the best institute for cancer care. Growth in Asia-Pacific is projected to be led by increasing investments in cancer research and treatment centers.

Competitive Players:

The report contains qualitative and quantitative research on the global tumor ablation market, as well as detailed insights and development strategies employed by the leading competitors.

Some of the main players in the global tumor ablation market include;     

  • Boston Scientific Corporation
  • SonaCare Medical
  • Ethicon Inc
  • Chongqing Haifu Medical Technology Co
  • Medtronic Plc
  • Neuwave Medical Inc

Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/tumor-ablation-market

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Recent Industry Developments:

  • In April 2022, the University of Alabama used NanoKnife, a new tumor ablation therapy. The NanoKnife is an image-guided, minimally invasive procedure that makes use of electric energy to destroy cancer cells
  • In January 2022, a private hospital in Mumbai, India witnessed the successful treatment of a patient in the early stage of liver cancer using a microwave ablation technique

The global tumor ablation market is segmented as follows:

By Application 

  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer

By Technology

  • Microwave Ablation
  • Radiofrequency Ablation
  • Irreversible Electroporation Ablation
  • Cryoablation
  • Others

By Treatment

  • Surgical Ablation
  • Laparoscopic Ablation
  • Percutaneous Ablation

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
    • Rest of Southeast Asia
  • The Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

For Additional Information on Global Tumor Ablation Market Players and Detail List, Download a Report PDF Brochure

Browse Other Related Research Reports from Facts & Factors:

About Facts & Factors:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors

USA: +1 347 690-0211 | UK: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 19999

Email: sales@fnfresearch.com | Web: https://www.fnfresearch.com

Follow Us on - LinkedIn | Twitter | Facebook

 Also Read Our Blogs: